• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对由柚皮苷组成的饲料添加剂进行评估,该添加剂适用于所有动物种类,以更新其授权(HealthTech Bio Actives, S.L.U.(HTBA))。

Assessment of the feed additive consisting of naringin for all animal species for the renewal of its authorisation (HealthTech Bio Actives, S.L.U. (HTBA)).

作者信息

Bampidis Vasileios, Azimonti Giovanna, Bastos Maria de Lourdes, Christensen Henrik, Dusemund Birgit, Fašmon Durjava Mojca, Kouba Maryline, López-Alonso Marta, López Puente Secundino, Marcon Francesca, Mayo Baltasar, Pechová Alena, Petkova Mariana, Ramos Fernando, Sanz Yolanda, Villa Roberto Edoardo, Woutersen Ruud, George Brantom Paul, Westendorf Johannes, Galobart Jaume, Manini Paola, Pizzo Fabiola

出版信息

EFSA J. 2022 Apr 22;20(4):e07267. doi: 10.2903/j.efsa.2022.7267. eCollection 2022 Apr.

DOI:10.2903/j.efsa.2022.7267
PMID:35615734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9026233/
Abstract

Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the assessment of the application for the renewal of authorisation of naringin as a sensory additive for all animal species. The applicant provided data demonstrating that the additive currently in the market complies with the conditions of authorisation. The FEEDAP Panel confirms that the use of naringin under the current authorised conditions of use is safe for the target species, the consumers and the environment. Naringin does not cause severe irritation or corrosion to eyes, is not irritant to the skin and is not classified as a dermal sensitiser. The FEEDAP Panel cannot conclude on the possible respiratory sensitisation of the additive, due to the lack of data. There was no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.

摘要

应欧盟委员会的要求,欧洲食品安全局动物饲料添加剂和产品或物质专家小组(FEEDAP)被要求就柚皮苷作为所有动物物种感官添加剂的授权续展申请评估发表科学意见。申请人提供的数据表明,目前市场上的该添加剂符合授权条件。FEEDAP小组确认,在当前授权使用条件下使用柚皮苷对目标物种、消费者和环境是安全的。柚皮苷不会对眼睛造成严重刺激或腐蚀,对皮肤无刺激性,且未被归类为皮肤致敏剂。由于缺乏数据,FEEDAP小组无法就该添加剂可能的呼吸道致敏作用得出结论。在授权续展的背景下,无需评估该添加剂的功效。

相似文献

1
Assessment of the feed additive consisting of naringin for all animal species for the renewal of its authorisation (HealthTech Bio Actives, S.L.U. (HTBA)).对由柚皮苷组成的饲料添加剂进行评估,该添加剂适用于所有动物种类,以更新其授权(HealthTech Bio Actives, S.L.U.(HTBA))。
EFSA J. 2022 Apr 22;20(4):e07267. doi: 10.2903/j.efsa.2022.7267. eCollection 2022 Apr.
2
Assessment of the application for renewal of authorisation of pyridoxine hydrochloride (vitamin B) as a feed additive for all animal species.对盐酸吡哆醇(维生素B)作为所有动物物种饲料添加剂的授权续展申请的评估。
EFSA J. 2020 Nov 13;18(11):e06289. doi: 10.2903/j.efsa.2020.6289. eCollection 2020 Nov.
3
Assessment of a feed additive consisting of vitamin B (pyridoxine hydrochloride) for all animal species for the renewal of its authorisation (Kaesler Nutrition GmbH).对一种由维生素B(盐酸吡哆醇)组成的用于所有动物物种的饲料添加剂进行重新授权评估(凯斯勒营养有限公司)。
EFSA J. 2021 Jun 9;19(6):e06612. doi: 10.2903/j.efsa.2021.6612. eCollection 2021 Jun.
4
Assessment of the feed additive consisting of niacinamide for all animal species for the renewal of its authorisation (Arxada Ltd).对由烟酰胺组成的、用于所有动物物种的饲料添加剂进行重新授权评估(阿克斯达有限公司)
EFSA J. 2023 Oct 19;21(10):e08357. doi: 10.2903/j.efsa.2023.8357. eCollection 2023 Oct.
5
Assessment of the feed additive consisting of (previously ) DSM 19457 for all animal species for the renewal of its authorisation (Biomin GmbH).对由(先前的)帝斯曼19457组成的饲料添加剂进行评估,以用于所有动物种类的授权续期(百奥明股份公司)。
EFSA J. 2023 Jan 6;21(1):e07697. doi: 10.2903/j.efsa.2023.7697. eCollection 2023 Jan.
6
Assessment of the feed additive consisting of DSM 11037 for all animal species for the renewal of its authorisation (Chr. Hansen A/S).对由DSM 11037组成的用于所有动物物种的饲料添加剂进行重新授权评估(科汉森公司)。
EFSA J. 2022 Apr 21;20(4):e07241. doi: 10.2903/j.efsa.2022.7241. eCollection 2022 Apr.
7
Assessment of the feed additive consisting of NCIMB 30160 for all animal species for the renewal of its authorisation (Lactosan GmbH & Co KG).评估由NCIMB 30160组成的饲料添加剂用于所有动物物种以更新其授权(Lactosan GmbH & Co KG)。
EFSA J. 2022 Jan 19;20(1):e06975. doi: 10.2903/j.efsa.2022.6975. eCollection 2022 Jan.
8
Assessment of the feed additive consisting of  DSM 22502 for all animal species for the renewal of its authorisation (Chr. Hansen A/S).对由DSM 22502组成的用于所有动物物种的饲料添加剂进行重新授权评估(科汉森公司)。
EFSA J. 2024 Mar 6;22(3):e8621. doi: 10.2903/j.efsa.2024.8621. eCollection 2024 Mar.
9
Assessment of the feed additive consisting of thaumatin for all animal species for the renewal of its authorisation (ADISSEO France S.A.S.).对由奇异果甜蛋白组成的、用于所有动物物种的饲料添加剂进行重新授权评估(法国安迪苏公司)。
EFSA J. 2023 Jun 12;21(6):e08077. doi: 10.2903/j.efsa.2023.8077. eCollection 2023 Jun.
10
Assessment of the feed additive consisting of niacin (nicotinic acid) for all animal species for the renewal of its authorisation (Arxada Ltd).对由烟酸(尼克酸)组成的用于所有动物物种的饲料添加剂进行重新授权评估(Arxada有限公司)。
EFSA J. 2023 Oct 25;21(10):e08359. doi: 10.2903/j.efsa.2023.8359. eCollection 2023 Oct.

引用本文的文献

1
Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins.天然化合物在骨重塑中的作用:一种针对与骨代谢相关蛋白的计算和实验方法。
Int J Mol Sci. 2024 May 6;25(9):5047. doi: 10.3390/ijms25095047.
2
Targeting bone homeostasis regulation: potential of traditional Chinese medicine flavonoids in the treatment of osteoporosis.靶向骨稳态调节:中药黄酮类化合物在骨质疏松症治疗中的潜力
Front Pharmacol. 2024 Apr 2;15:1361864. doi: 10.3389/fphar.2024.1361864. eCollection 2024.

本文引用的文献

1
Safety and efficacy of a feed additive consisting of a flavonoid-rich dried extract of  ×  L. fruit (bitter orange extract) for use in all animal species (FEFANA asbl).一种由×L.果实富含类黄酮的干燥提取物(苦橙提取物)组成的饲料添加剂在所有动物物种中的安全性和有效性(FEFANA asbl)。
EFSA J. 2021 Jul 27;19(7):e06709. doi: 10.2903/j.efsa.2021.6709. eCollection 2021 Jul.
2
Guidance on the renewal of the authorisation of feed additives.饲料添加剂授权续期指南。
EFSA J. 2021 Jan 7;19(1):e06340. doi: 10.2903/j.efsa.2021.6340. eCollection 2021 Jan.
3
Scientific Opinion of Flavouring Group Evaluation 410 (FGE.410): 4',5,7-trihydroxyflavanone from chemical group 25 (phenol derivatives containing ring-alkyl, ring-alkoxy, and side-chains with an oxygenated functional group).调味剂组评估410(FGE.410)的科学意见:来自化学组25(含有环烷基、环烷氧基和带有氧化官能团侧链的酚衍生物)的4',5,7-三羟基黄烷酮
EFSA J. 2017 Nov 15;15(11):e05011. doi: 10.2903/j.efsa.2017.5011. eCollection 2017 Nov.
4
Guidance on the assessment of the safety of feed additives for the target species.目标物种饲料添加剂安全性评估指南。
EFSA J. 2017 Oct 17;15(10):e05021. doi: 10.2903/j.efsa.2017.5021. eCollection 2017 Oct.
5
The Genoprotective Role of Naringin.柚皮苷的基因保护作用。
Biomolecules. 2020 Apr 30;10(5):700. doi: 10.3390/biom10050700.
6
Pharmacokinetics and Metabolism of Naringin and Active Metabolite Naringenin in Rats, Dogs, Humans, and the Differences Between Species.柚皮苷及其活性代谢产物柚皮素在大鼠、犬、人类体内的药代动力学与代谢以及种属差异
Front Pharmacol. 2020 Mar 27;11:364. doi: 10.3389/fphar.2020.00364. eCollection 2020.
7
Toxicological evaluation of naringin: Acute, subchronic, and chronic toxicity in Beagle dogs.柚皮苷的毒理学评价:比格犬的急性、亚慢性和慢性毒性。
Regul Toxicol Pharmacol. 2020 Mar;111:104580. doi: 10.1016/j.yrtph.2020.104580. Epub 2020 Jan 16.
8
Metabolite Profiling of Naringin in Rat Urine and Feces Using Stable Isotope-Labeling-Based Liquid Chromatography-Mass Spectrometry.采用基于稳定同位素标记的液相色谱-质谱联用技术对大鼠尿液和粪便中的柚皮苷代谢产物进行分析。
J Agric Food Chem. 2020 Jan 8;68(1):409-417. doi: 10.1021/acs.jafc.9b06494. Epub 2019 Dec 24.
9
Tissue distribution of naringin and derived metabolites in rats after a single oral administration.单次口服给药后大鼠体内柚皮苷及其代谢产物的组织分布
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jan 1;1136:121846. doi: 10.1016/j.jchromb.2019.121846. Epub 2019 Oct 31.
10
Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Naringin in Aged Rats.柚皮苷在老年大鼠体内的药代动力学、组织分布、代谢及排泄
Front Pharmacol. 2019 Jan 28;10:34. doi: 10.3389/fphar.2019.00034. eCollection 2019.